Beta Bionics Cash Flow Statement (2023-2025) | BBNX

Cash Flow Statement Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -8.31M-10.79M-10.15M-12.09M-16.21M-16.87M-14.21M
Depreciation and Depletion 0.30M0.30M0.32M0.28M0.30M0.35M0.39M
Share-based Compensation 1.36M1.50M1.98M1.55M2.80M4.80M4.48M
Gains from Sales and Divestitures 0.10M0.19M
Gains from Investment Securities 5.20M4.14M3.67M-0.42M6.02M12.45M
Asset Writedowns and Impairment 0.02M0.03M0.03M0.02M
Non-cash Items 0.54M2.89M46.21M43.84M3.54M
Cash from Operations -12.14M-12.24M-9.61M-14.28M-19.98M-13.59M-8.73M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.28M0.28M0.28M0.30M0.30M0.31M0.30M
Depreciation & Amortization (CF) 0.30M0.30M0.32M0.28M0.30M0.35M0.39M
Change in Working Capital
Change in Receivables 1.92M2.64M-1.50M4.56M-2.94M2.33M0.17M
Change in Inventory 2.41M3.89M3.93M1.21M2.62M1.73M3.33M
Change in Account Payables 0.41M1.06M0.11M-0.06M-0.10M0.57M1.10M
Change in Accured Expenses -0.23M2.30M1.20M3.57M-5.27M2.72M4.12M
Other Working Capital Changes 1.06M0.08M0.58M1.13M0.01M0.02M0.02M
Investing Activities
Capital Expenditures 0.41M0.55M1.88M0.56M0.70M1.41M1.28M
Sales of Property, Plant and Equipment 0.05M
Change in Acquisitions & Divestments 8.00M24.00M24.00M16.00M28.00M23.00M71.00M
Cash from Investing Activities 7.64M3.30M15.24M-29.66M-179.12M6.17M9.49M
Financing Activities
Other financing activities 1.22M2.81M
Cash from Financing Activities 0.01M-0.11M-1.18M56.89M211.12M0.04M2.65M
Additional items
Change in Cash -4.49M-9.04M4.45M12.95M12.02M-7.38M3.41M
Free Cash Flow -12.55M-12.79M-11.49M-14.84M-20.67M-15.01M-10.01M
Net Cash Flow -4.49M-9.04M4.45M12.95M12.02M-7.38M3.41M